This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Is Ackman Most Hated?; Facebook Immune to Google Monster: Cramer's Best Blogs

Now, Google has its own programming and its own ad-serving system, and the great thing about the latter is also the bad thing: Google gives the advertiser a bargain but hurts the content providers, including itself. Unless you have a proprietary product with a proprietary ad sales force to sell that product in a way that can't be compromised by what's known as programmatic selling -- a cheap form of advertising in which you carpet-bomb every site imaginable, and the purveyors of the sites are offered a take-it-or-leave-it deal, and most take it -- you aren't going to make as much money as you should.

Incredibly, Google has created a monster here that only Facebook right now is immune to, hence the incredible run that Facebook is having.

But Google said it is just a quarter behind in doing this itself. Why should we not take Google at its word? I believe it has the smarts to figure this out.
[Read: <a target="blank" data-add-tracking="true" href=""><em>401(k) Plan Contribution Rates Remain Steady but Loans Still Elevated</em></a>]

That's why, even as Facebook soars here, I believe Google at this point is the better buy. Yes, you may have to buy it in a stock-replacement way, using deep-in-the-money calls to get some bang for the buck, but right now there is no doubt in my mind that it is the cheaper stock to own, if you are willing to own it until the next quarter is reported.

At the time of publication, Action Alerts PLUS, which Cramer co-manages as a charitable trust, was long FB.

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV


DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Our Tweets

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs